Jocelynn Casselle
Adult Health · Largo, MDNPI 1174959704
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 10.3% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $92.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$471
- AbbVie$465
- Neurocrine Biosciences, Inc.$250
- Novo Nordisk$215
- Boston Scientific$208
- Amgen$201
- plus $3K from 25 others
What the payments were for
- Food & beverage$4,556100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 5 | $471 |
| AbbVie | 5 | $465 |
| Neurocrine Biosciences, Inc. | 2 | $250 |
| Novo Nordisk | 2 | $215 |
| Boston Scientific | 3 | $208 |
| Amgen | 2 | $201 |
| Myriad Genetic Laboratories, Inc. | 1 | $183 |
| Sanofi Pasteur Inc. | 2 | $182 |
| Vertex | 2 | $168 |
| EMD Serono, Inc. | 2 | $166 |
| Biogen | 2 | $141 |
| Dexcom, Inc. | 1 | $135 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $122 |
| Novartis | 1 | $118 |
| Vertos Medical, Inc. | 1 | $117 |
| Coloplast | 1 | $110 |
| Hologic Sales And Service, LLC | 1 | $110 |
| Idorsia Pharmaceuticals US Inc | 1 | $110 |
| BD | 1 | $107 |
| Teva Pharmaceuticals USA, Inc. | 1 | $102 |
| Otsuka America Pharmaceutical, Inc. | 1 | $101 |
| KCI USA, Inc. | 1 | $98 |
| Ironshore Pharmaceuticals Inc. | 2 | $94 |
| Insmed, Inc. | 1 | $93 |
| Janssen Scientific Affairs, LLC | 1 | $93 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $88 |
| Jazz Pharmaceuticals Inc. | 1 | $83 |
| Sanofi | 1 | $81 |
| Ultragenyx Pharmaceutical Inc. | 1 | $63 |
| Solventum Corporation | 1 | $55 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$250
- myRisk$183
- DEXCOM G7 GSS (161)$135
- DEXCOM STELO GLUCOSE BIOSENSOR$135
- ULTOMIRIS$122
- NEFFY$122
- LEQVIO$118
- mild Device Kit$117
- Saxenda$117
- Strensiq$112
- TITAN$110
- Aptima$110
- QUVIVIQ$110
- BD Nano 2nd Gen Pen Needle$107
- Austedo XR$102
- REXULTI$101
- SOLIRIS$101
How this compares
$4,556 in reported general payments places this provider in the 90th percentile of 542 adult health providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $364 |
| Atorvastatin Calcium | 13 | $71 |
| Amlodipine Besylate | 11 | $46 |
Paid to pharmacies, not to this prescriber.
Other adult health in Largo
- Lucia NovakCamp Springs$473K
- Caroline RuhlAnnapolis$315K
- Joyce MiskovicHighland$264K
- Christopher RobersonBaltimore$180K
- Amit DhirBaltimore$97K
- Morgan JoliatSykesville$92K
- Brendon BowerBaltimore$64K
- Caitlin NassBaltimore$46K
- Jane KapustinClarksville$44K
- Sarah RileyBaltimore$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.